InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,408.42
(
-1.73%
)
US TECH 100
17,870.94
(
-3.09%
)
Dow Jones
40,345.41
(
-1.01%
)
Brent Oil
71.80
(
0.36%
)
Bitcoin
54,984.08
(
0.21%
)
Post# of 403427
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

KMBJN

Send PM Follow Ignore
Followers 52
Posts 2237
Boards Moderated 0
Alias Born 07/06/2011

KMBJN

Re: Amatuer17 post# 211926

Monday, 01/08/2018 12:12:05 PM

Monday, January 08, 2018 12:12:05 PM

Post# of 403427
Kevetrin and IPIX remain under the radar for now.

Kevetrin MOA studies and publications should help that, along with a big partner signing on to help develop it, and/or clinical results.

The other p53 mutant activating drugs show they reactivate mutant p53 by knocking it out and seeing that the drugs don't stop cancer quite as well in the dish.

This statement is also important:

"It remains to be shown however, whether any mutant p53 reactivating compound has ef?cacy for the treatment of human cancer."

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM

Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM

VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM

Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM

Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM

Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!